產(chǎn)品名稱：Recombinant Human TWEAK 5 ug 產(chǎn)品貨號(hào)：eBioscience 14-8916-62 產(chǎn)品規(guī)格：5 ug Human CD255 (TWEAK) Recombinant Protein Also known as: TNF-related weak inducer of apoptosis, APO3L RUO: For Research Use Only. Not for use in diagnostic procedures. SKU# 14-8916 Cat. No. Size 14-8916-62 5 ug Description: TWEAK, TNF-like weak inducer of apoptosis, is a member of the TNF family of proteins. TWEAK has the same sequence as APO-3 ligand. Based on homology with other members of the TNF ligand protein superfamily, the ligand is referred to also as TNF ligand superfamily member 12 [ TNFSF12 ]. TWEAK induces IL-8 synthesis in a number of cell lines. TWEAK induces cell death by apoptosis in the human adenocarcinoma cell line HT29 in the presence of IFN-γ. It's been reported that TWEAK contributes to macrophage homeostasis by mediating CD4 (+)T-cell killing of antigen-presenting macrophages. It's been reported that TWEAK plays a role in brain inflammation . Human astrocytes derived from different regions of the brain specifically bind TWEAK and are resistant to apoptosis mediated by TWEAK. TWEAK induces the production of large amounts of IL-8 and IL-6 in astrocytes and significantly increases the expression of ICAM-1. The TWEAK receptor has been cloned from a human umbilical vein endothelial cell library. The short cytoplasmic domain of this receptor binds TRAF-1 , TRAF-2 , and TRAF-3. Cross-linking of this receptor induces growth of human umbilical vein endothelial cells. The soluble receptor has been shown to inhibit endothelial cell migration in vitro and corneal angiogenesis in vivo.
滬公網(wǎng)安備 31011002002623號(hào)
